Latest Breaking News On - Pennant investors - Page 1 : comparemela.com

BioXcel Therapeutics, Inc (NASDAQ:BTAI) CEO Vimal Mehta Sells 126,014 Shares

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares of the […]

United statesVimal mehtaTower research capitalTruist financial corpVirtu financialCanaccord genuity groupBioxcel therapeutics company profileApollon wealth managementBioxcel therapeutics incBioxcel therapeuticsGet free reportXcel therapeutics trading downXcel therapeuticsWealth managementFinancial corpResearch capital

EchoStar (NASDAQ:SATS) Upgraded at StockNews com

StockNews.com upgraded shares of EchoStar (NASDAQ:SATS – Free Report) to a sell rating in a report issued on Tuesday morning. A number of other brokerages have also weighed in on SATS. TD Cowen reduced their price target on EchoStar from $39.00 to $38.00 and set an outperform rating on the stock in a research note […]

James defrancoSatellite servicesPennant selectMorgan stanleyVanguard group inc5g network deploymentBeryl capital managementEchostar corporationFree reportGet free reportDirector james defrancoAsset managementCapital managementPennant investorsStar corporationRetail wireless

Short Interest in IGM Biosciences, Inc (NASDAQ:IGMS) Rises By 18 9%

Short Interest in IGM Biosciences, Inc (NASDAQ:IGMS) Rises By 18 9%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Hudson bayFred schwarzerBiosciences incIgm biosciences incTd asset management incCapital partnersRoyal bankSecurities exchange commissionGet free reportAdvisors lp bakerExchange commissionPartners asset managementBay capital managementManagement incPennant investorsDeath receptor

Allakos (NASDAQ:ALLK) Trading Down 7%

Allakos (NASDAQ:ALLK) Trading Down 7%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesTd asset management incAristides capitalAllakos company profileAllakos incCantor fitzgeraldJefferies financial groupSg americas securitiesGet free reportFinancial groupTrading downManagement incPennant investorsAllakos daily

FibroGen, Inc to Post Q1 2025 Earnings of $0 00 Per Share, William Blair Forecasts (NASDAQ:FGEN)

FibroGen, Inc to Post Q1 2025 Earnings of $0 00 Per Share, William Blair Forecasts (NASDAQ:FGEN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William blairSecurities exchange commissionFibrogen incArmistice capitalAcadian asset managementPrimecap management coFree reportGen trading downGet free reportExchange commissionAsset managementPennant investorsFibrogen daily